BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37670964)

  • 1. Differences in Colorectal Cancer Survival Based on Primary Tumor Location: Retrospective Study from a Single Institution.
    Diez-Alonso M; Mendoza-Moreno F; Ortega MA; Aguado H; Matías B; Vera C; Soto S; Quiroga A; Blazquez SB; de Mon MA; Gutierrez-Calvo A
    J Cancer; 2023; 14(13):2444-2454. PubMed ID: 37670964
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule?
    Kamphues C; Lefevre JH; Wang J; Amini N; Beaugerie L; Kuehn F; Park SH; Andreatos N; Lauscher JC; Enea D; Lehmann KS; Peru N; Weixler B; Kirchgesner J; Degro CE; Pozios I; van Beekum CJ; Schölch S; Zambonin D; Schineis C; Loch FN; Geka D; Theoxari M; Wu B; Wang PP; Antoniou E; Pikoulis E; Moussata D; Theodoropoulos G; Ouaissi M; Seeliger H; Inaba Y; Scaringi S; Reißfelder C; Vilz TO; Lin C; Yang SK; Beyer K; Renz BW; Sasaki K; Margonis GA; Svrcek M; Kreis ME
    Surg Oncol; 2022 Dec; 45():101874. PubMed ID: 36257179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryologic Origin of the Primary Tumor and RAS Status Predict Survival after Resection of Colorectal Liver Metastases.
    Alexandrescu ST; Dinu IM; Diaconescu AS; Micu A; Pasare E; Durdu C; Dorobantu BM; Popescu I
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
    Margonis GA; Amini N; Buettner S; Kim Y; Wang J; Andreatos N; Wagner D; Sasaki K; Beer A; Kamphues C; Morioka D; Løes IM; Imai K; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Burkhart R; Endo I; Baba H; Mischinger HJ; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    Ann Surg; 2021 Jun; 273(6):1165-1172. PubMed ID: 31389831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
    Kamphues C; Kadowaki S; Amini N; van den Berg I; Wang J; Andreatos N; Sakamoto Y; Ogura T; Kakuta M; Pikouli A; Geka D; Daitoku N; Theochari M; Buettner S; Akiyama T; Antoniou E; Pikoulis E; Theodoropoulos G; Imai K; Ijzermans JNM; Margonis GA; Akagi K; Kreis ME
    J Surg Oncol; 2021 Mar; 123(4):1005-1014. PubMed ID: 33368279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status.
    Kim HS; Lee JM; Kim HS; Yang SY; Han YD; Cho MS; Hur H; Min BS; Lee KY; Kim NK
    Ann Surg Oncol; 2020 Dec; 27(13):5150-5158. PubMed ID: 32812112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term oncologic outcomes of stage III colorectal cancer following laparoscopic versus open surgery.
    Baek JH; Lee GJ; Lee WS
    Ann Surg Treat Res; 2015 Jan; 88(1):8-14. PubMed ID: 25553319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of distal spread differs according to the primary tumor location in rectal cancer.
    Abe K; Shimada Y; Oyanagi H; Yagi R; Nakano M; Kameyama H; Nogami H; Maruyama S; Takii Y; Wakai T
    Surg Today; 2020 Apr; 50(4):360-368. PubMed ID: 31571012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
    Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y
    Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic scoring system based on eosinophil- and basophil-related markers for predicting the prognosis of patients with stage II and stage III colorectal cancer: a retrospective cohort study.
    Gao L; Yuan C; Fu J; Tian T; Huang H; Zhang L; Li D; Liu Y; Meng S; Liu Y; Zhang Y; Xu J; Jia C; Zhang D; Zheng T; Fu Q; Tan S; Lan L; Yang C; Zhao Y; Liu Y
    Front Oncol; 2023; 13():1182944. PubMed ID: 37519795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
    Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
    Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Wang K; Xu D; Yan XL; Poston G; Xing BC
    Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
    Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
    Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
    Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
    Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study.
    Wang CB; Shahjehan F; Merchea A; Li Z; Bekaii-Saab TS; Grothey A; Colibaseanu DT; Kasi PM
    Front Oncol; 2019; 9():76. PubMed ID: 30838175
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.